| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Nov 17, 2022 | Athira Pharma, Inc. | Chief Medical Officer | Buy | 86.3 | +5,000 | 8.22% | ✗ | $16.4K |
| Jun 28, 2022 | Jun 30, 2022 | Athira Pharma, Inc. | Chief Medical Officer | Buy | 91.3 | +10,000 | 23.28% | ✗ | $28.8K |